RESUMEN
A young woman presented with a perianal nodular lesion, which was found to have histopathological findings of hidradenoma papilliferum. The anal skin is an uncommon location for this neoplasm.
Asunto(s)
Neoplasias de las Glándulas Sudoríparas/patología , Adenomas Tubulares de las Glándulas Sudoríparas/patología , Adulto , Femenino , Humanos , Perineo/patologíaRESUMEN
BACKGROUND: Panniculitis occurring in dermatomyositis is uncommon, with only a few cases described in the literature, most of them as case reports. OBJECTIVE: This report describes the clinicopathological and immunohistochemical findings in a series of 18 patients with panniculitis associated with dermatomyositis. METHODS: In each patient, we collected the clinical data of the cutaneous lesions as well as the characteristic clinical and laboratory findings. A series of histopathologic findings was recorded in the biopsy of each patient. A panel of antibodies was used in some cases to investigate the immunophenotype of the infiltrate. Data of treatment and follow-up were also collected. RESULTS: Of the 18 patients, 13 were female and 5 were male, ranging in age from 13 to 74 years (median, 46.4 years). In addition to panniculitis, all patients presented pathognomonic cutaneous findings of DM and reported proximal muscle weakness prior to the diagnosis of panniculitis. Muscle biopsy was performed in 17 patients and MRI in one, all with the diagnosis of inflammatory myopathy. None of the patients presented any associated neoplasia. Panniculitis lesions were located in the upper or lower limbs. Histopathology showed a mostly lobular panniculitis with lymphocytes as the main component of the infiltrate. Most cases showed also numerous plasma cells and lymphocytes surrounding necrotic adipocytes (rimming) were frequently seen. Lymphocytic vasculitis and abundant mucin interstitially deposited between collagen bundles of the dermis were also frequent findings. Late-stage lesions showed hyaline necrosis of the fat lobule and calcification. Immunohistochemistry demonstrated that most lymphocytes of the infiltrate were T-helper lymphocytes, with some B lymphocytes in the lymphoid aggregates and small clusters of CD-123-positive plasmacytoid dendritic cells in the involved fat lobule. CONCLUSION: Panniculitis in dermatomyositis is rare. Histopathologic findings of panniculitis dermatomyositis are identical to those of lupus panniculitis. Therefore, the final diagnosis requires clinic-pathologic correlation.
Asunto(s)
Dermatomiositis/metabolismo , Dermatomiositis/patología , Paniculitis/metabolismo , Paniculitis/patología , Adolescente , Adulto , Anciano , Linfocitos B/patología , Biopsia , Células Dendríticas/metabolismo , Células Dendríticas/patología , Dermatomiositis/complicaciones , Femenino , Humanos , Subunidad alfa del Receptor de Interleucina-3/metabolismo , Masculino , Persona de Mediana Edad , Músculo Esquelético/patología , Paniculitis/complicaciones , Linfocitos T Colaboradores-Inductores/patología , Adulto JovenRESUMEN
Brown adipose tissue (BAT) plays an important role in lipid and glucose metabolism in rodents and possibly also in humans. Identification of genes responsible for BAT function would shed light on underlying pathophysiological mechanisms of metabolic disturbances. Recent linkage analysis in the BXH/HXB recombinant inbred (RI) strains, derived from Brown Norway (BN) and spontaneously hypertensive rats (SHR), identified two closely linked quantitative trait loci (QTL) associated with glucose oxidation and glucose incorporation into BAT lipids in the vicinity of Wars2 (tryptophanyl tRNA synthetase 2 (mitochondrial)) gene on chromosome 2. The SHR harbors L53F WARS2 protein variant that was associated with reduced angiogenesis and Wars2 thus represents a prominent positional candidate gene. In the current study, we validated this candidate as a quantitative trait gene (QTG) using transgenic rescue experiment. SHR-Wars2 transgenic rats with wild type Wars2 gene when compared to SHR, showed more efficient mitochondrial proteosynthesis and increased mitochondrial respiration, which was associated with increased glucose oxidation and incorporation into BAT lipids, and with reduced weight of visceral fat. Correlation analyses in RI strains showed that increased activity of BAT was associated with amelioration of insulin resistance in muscle and white adipose tissue. In summary, these results demonstrate important role of Wars2 gene in regulating BAT function and consequently lipid and glucose metabolism.
Asunto(s)
Tejido Adiposo Pardo/metabolismo , Metabolismo Energético , Grasa Intraabdominal/metabolismo , Mutación , Obesidad/genética , Triptófano-ARNt Ligasa/genética , Tejido Adiposo Pardo/patología , Animales , Células Cultivadas , Metabolismo Energético/genética , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Glucosa/metabolismo , Grasa Intraabdominal/fisiopatología , Metabolismo de los Lípidos , Masculino , Mitocondrias/metabolismo , Obesidad/metabolismo , Obesidad/fisiopatología , Fenotipo , Sitios de Carácter Cuantitativo , Ratas Endogámicas SHRAsunto(s)
Hemangioendotelioma/metabolismo , Proteínas de Fusión Oncogénica/metabolismo , Inhibidor 1 de Activador Plasminogénico/metabolismo , Proteínas Proto-Oncogénicas c-fos/metabolismo , Neoplasias Cutáneas/metabolismo , Adulto , Femenino , Hemangioendotelioma/genética , Humanos , Proteínas de Fusión Oncogénica/genética , Inhibidor 1 de Activador Plasminogénico/genética , Proteínas Proto-Oncogénicas c-fos/genética , Neoplasias Cutáneas/genéticaRESUMEN
The spontaneously hypertensive rat (SHR) is the most widely used animal model of essential hypertension and left ventricular hypertrophy. Catecholamines play an important role in the pathogenesis of both essential hypertension in humans and in the SHR. Recently, we obtained evidence that the SHR harbors a variant in the gene for dopamine beta hydroxylase (Dbh) that is associated with reduced adrenal expression of Dbh mRNA and reduced DBH enzymatic activity which correlated negatively with blood pressure. In the current study, we used a transgenic experiment to test the hypothesis that reduced Dbh expression predisposes the SHR to hypertension and that augmentation of Dbh expression would reduce blood pressure. We derived 2 new transgenic SHR-Dbh lines expressing Dbh cDNA under control of the Brown Norway (BN) wild type promoter. We found modestly increased adrenal expression of Dbh in transgenic rats versus SHR non-transgenic controls that was associated with reduced adrenal levels of dopamine and increased plasma levels of norepinephrine and epinephrine. The observed changes in catecholamine metabolism were associated with increased blood pressure and left ventricular mass in both transgenic lines. We did not observe any consistent changes in brainstem levels of catecholamines or of mRNA levels of Dbh in the transgenic strains. Contrary to our initial expections, these findings are consistent with the possibility that genetically determined decreases in adrenal expression and activity of DBH do not represent primary determinants of increased blood pressure in the SHR model.
Asunto(s)
Presión Sanguínea/genética , Dopamina beta-Hidroxilasa/biosíntesis , Dopamina beta-Hidroxilasa/genética , Hipertensión/genética , Hipertensión/fisiopatología , Glándulas Suprarrenales/enzimología , Animales , Animales Modificados Genéticamente , Tronco Encefálico/metabolismo , ADN Complementario/biosíntesis , ADN Complementario/genética , Dopamina/metabolismo , Epinefrina/metabolismo , Regulación Enzimológica de la Expresión Génica/genética , Norepinefrina/metabolismo , Ratas , Ratas Endogámicas BN , Ratas Endogámicas SHR , TransgenesRESUMEN
Dyslipidemia and inflammation play an important role in the pathogenesis of cardiovascular and liver disease. Fenofibrate has a well-known efficacy to reduce cholesterol and triglycerides. Combination with statins can ameliorate hypolipidemic and anti-inflammatory effects of fibrates. In the current study, we tested the anti-inflammatory and metabolic effects of fenofibrate alone and in combination with rosuvastatin in a model of inflammation and metabolic syndrome, using spontaneously hypertensive rats expressing the human C-reactive protein transgene (SHR-CRP transgenic rats). SHR-CRP rats treated with fenofibrate alone (100 mg/kg body weight) or in combination with rosuvastatin (20 mg/kg body weight) vs. SHR-CRP untreated controls showed increased levels of proinflammatory marker IL6, increased concentrations of ALT, AST and ALP, increased oxidative stress in the liver and necrotic changes of the liver. In addition, SHR-CRP rats treated with fenofibrate, or with fenofibrate combined with rosuvastatin vs. untreated controls, exhibited increased serum triglycerides and reduced HDL cholesterol, as well as reduced hepatic triglyceride, cholesterol and glycogen concentrations. These findings suggest that in the presence of high levels of human CRP, fenofibrate can induce liver damage even in combination with rosuvastatin. Accordingly, these results caution against the possible hepatotoxic effects of fenofibrate in patients with high levels of CRP.
Asunto(s)
Proteína C-Reactiva/genética , Enfermedad Hepática Inducida por Sustancias y Drogas/genética , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Fenofibrato/toxicidad , Hipolipemiantes/toxicidad , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Animales , Glucosa/metabolismo , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Pruebas de Función Hepática , Masculino , Síndrome Metabólico/metabolismo , Ratas , Ratas Endogámicas SHR , Ratas Transgénicas , Rosuvastatina Cálcica/farmacología , Estearoil-CoA Desaturasa/genética , Estearoil-CoA Desaturasa/metabolismoRESUMEN
Recently, we derived "humanized" spontaneously hypertensive rats (SHR-CRP) in which transgenic expression of human CRP induces inflammation, oxidative stress, several features of metabolic syndrome and target organ injury. In addition, we found that rosuvastatin treatment of SHR-CRP transgenic rats can protect against pro-inflammatory effects of human CRP and also reduce cardiac inflammation and oxidative damage. In the current study, we tested the effects of rosuvastatin (5 mg/kg) on kidney injury in SHR-CRP males versus untreated SHR-CRP and SHR controls. All rats were fed a high sucrose diet. In SHR-CRP transgenic rats, treatment with rosuvastatin for 10 weeks, compared to untreated transgenic rats and SHR controls, was associated with significantly reduced systemic inflammation which was accompanied with activation of antioxidative enzymes in the kidney, lower renal fat accumulation, and with amelioration of histopathological changes in the kidney. These findings provide evidence that, in the presence of high CRP levels, rosuvastatin exhibits significant anti-inflammatory, anti-oxidative, and renoprotective effects.
Asunto(s)
Lesión Renal Aguda/tratamiento farmacológico , Adiposidad/efectos de los fármacos , Proteína C-Reactiva/inmunología , Inflamación/tratamiento farmacológico , Riñón/inmunología , Rosuvastatina Cálcica/uso terapéutico , Lesión Renal Aguda/inmunología , Animales , Proteína C-Reactiva/genética , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Hipertensión/tratamiento farmacológico , Hipertensión/inmunología , Riñón/efectos de los fármacos , Masculino , Ratas , Ratas Endogámicas SHR , Ratas Transgénicas , Resultado del TratamientoRESUMEN
Cold exposure of rats leads to ameliorated glucose and triglyceride utilization with females displaying better adaptation to a cold environment. In the current study, we used hairless rats as a model of increased thermogenesis and analyzed gender-related effects on parameters of lipid and glucose metabolism in the spontaneously hypertensive (SHR) rats. Specifically, we compared hairless coisogenic SHR-Dsg4 males and females harboring mutant Dsg4 (desmoglein 4) gene versus their SHR wild type controls. Two way ANOVA showed significant Dsg4 genotype (hairless or wild type) x gender interaction effects on palmitate oxidation in brown adipose tissue (BAT), glucose incorporation into BAT determined by microPET, and glucose oxidation in skeletal muscles. In addition, we observed significant interaction effects on sensitivity of muscle tissue to insulin action when Dsg4 genotype affected these metabolic traits in males, but had little or no effects in females. Both wild type and hairless females and hairless males showed increased glucose incorporation and palmitate oxidation in BAT and higher tissue insulin sensitivity when compared to wild type males. These findings provide evidence for gender-related differences in metabolic adaptation required for increased thermogenesis. They are consistent with the hypothesis that increased glucose and palmitate utilization in BAT and muscle is associated with higher sensitivity of adipose and muscle tissues to insulin action.
Asunto(s)
Tejido Adiposo Pardo/metabolismo , Frío , Metabolismo Energético , Hipertensión/metabolismo , Músculo Esquelético/metabolismo , Termogénesis , Adaptación Fisiológica , Tejido Adiposo Pardo/fisiopatología , Adiposidad , Animales , Desmogleínas/genética , Modelos Animales de Enfermedad , Ingestión de Alimentos , Metabolismo Energético/genética , Femenino , Regulación de la Expresión Génica , Genotipo , Glucosa/metabolismo , Hipertensión/genética , Hipertensión/fisiopatología , Insulina/metabolismo , Masculino , Músculo Esquelético/fisiopatología , Mutación , Oxidación-Reducción , Ácido Palmítico/metabolismo , Fenotipo , Ratas sin Pelo , Ratas Endogámicas SHR , Factores Sexuales , Termogénesis/genéticaRESUMEN
It has been reported that the major function of the sterol regulatory element binding protein 2 (SREBP-2) is to activate preferentially cholesterol biosynthesis in liver and adipose tissue rather than fatty acid synthesis. In the current study, we analyzed the effects of overexpression of human dominant-positive SREBP-2 transgene under control of PEPCK promoter in the spontaneously hypertensive rat (SHR) on lipid and glucose metabolism. Transgenic overexpression of SREBP-2 was associated with significantly higher hepatic triglycerides (20.4+/-0.9 vs. 17.0+/-0.05 micromol/g, P<0.05) but not cholesterol (10.6+/-0.4 vs. 10.9+/-0.4 micromol/g) and decreased relative weight of epididymal fat pad (0.73+/-0.03 vs. 0.83+/-0.03, P<0.05). In addition, muscle triglyceride (15.8+/-3.7 vs. 8.5+/-1.2 micromol/g, P<0.001) and cholesterol (3.6+/-0.5 vs. 2.1+/-0.1 micromol/g, P<0.05) concentrations were significantly increased in transgenic rats when compared to SHR controls. Ectopic fat accumulation was associated with significantly increased serum glucose levels (6.4+/-0.1 vs. 5.9+/-0.1 mmol/l, P<0.005) and reduced insulin levels (1.78+/-0.33 vs. 2.73+/-0.37 nmol/l, P<0.05) in transgenic rats. These results provide evidence for important role of SREBP-2 in regulation of lipid and glucose metabolism.
Asunto(s)
Adipogénesis , Tejido Adiposo/metabolismo , Adiposidad , Hipertensión/metabolismo , Proteína 2 de Unión a Elementos Reguladores de Esteroles/metabolismo , Tejido Adiposo/fisiopatología , Animales , Glucemia/metabolismo , Colesterol/metabolismo , Modelos Animales de Enfermedad , Humanos , Hipertensión/sangre , Hipertensión/genética , Hipertensión/fisiopatología , Insulina/sangre , Péptidos y Proteínas de Señalización Intracelular/genética , Hígado/metabolismo , Fosfoenolpiruvato Carboxiquinasa (GTP)/genética , Regiones Promotoras Genéticas , Ratas Endogámicas SHR , Ratas Transgénicas , Proteína 2 de Unión a Elementos Reguladores de Esteroles/genética , Triglicéridos/metabolismoRESUMEN
The spontaneously hypertensive rat (SHR) is the most widely used animal model of essential hypertension and accompanying metabolic disturbances. Recent advances in sequencing of genomes of BN-Lx and SHR progenitors of the BXH/HXB recombinant inbred (RI) strains as well as accumulation of multiple data sets of intermediary phenotypes in the RI strains, including mRNA and microRNA abundance, quantitative metabolomics, proteomics, methylomics or histone modifications, will make it possible to systematically search for genetic variants involved in regulation of gene expression and in the etiology of complex pathophysiological traits. New advances in manipulation of the rat genome, including efficient transgenesis and gene targeting, will enable in vivo functional analyses of selected candidate genes to identify QTL at the molecular level or to provide insight into mechanisms whereby targeted genes affect pathophysiological traits in the SHR.
Asunto(s)
Resistencia a la Insulina/genética , Síndrome Metabólico/genética , Sitios de Carácter Cuantitativo/genética , Ratas Endogámicas SHR/genética , Ratas Transgénicas/genética , Animales , Humanos , Síndrome Metabólico/clasificación , Ratas , Ratas Endogámicas SHR/clasificación , Especificidad de la EspecieRESUMEN
OBJECTIVE: To investigate the mechanism by which fat-specific transgenic expression of resistin affects fatty acid metabolism in the spontaneously hypertensive rat (SHR). DESIGN: Basal- and adrenaline-stimulated lipolysis, basal- and insulin-stimulated lipogenesis as well as the site (glycerol versus acyl moiety) of glucose incorporated into triglycerides were determined in adipose tissue isolated from SHR-Resistin transgenic and SHR control rats. RESULTS: A moderate expression of transgenic resistin in adipose tissue was associated with significant increase in the FFA/glycerol ratio during adrenaline-stimulated lipolysis in the SHR-Resistin transgenic rats (3.27+/-0.26) compared to SHR controls (2.11+/-0.10, P=0.0005). Transgenic SHR also exhibited a significant decrease in FFA re-esterification in adipose tissue (approximately by 23%). CONCLUSION: These findings raise the possibility that the prodiabetic effects of transgenic resistin may be partly mediated by increased FFA release from adipose tissue due to impaired FFA re-esterification in adipocytes.
Asunto(s)
Tejido Adiposo/metabolismo , Ácidos Grasos no Esterificados/metabolismo , Resistina/fisiología , Adipocitos/metabolismo , Animales , Animales Modificados Genéticamente , Epinefrina/farmacología , Esterificación , Glucosa/metabolismo , Glicerol/metabolismo , Lipólisis/efectos de los fármacos , Lipólisis/fisiología , Ratas , Ratas Endogámicas SHR , Resistina/genética , Resistina/metabolismoRESUMEN
Early bovine precompacted embryos (at 1- to 8-blastomere stage) were analyzed by electron microscopy. The volume density of cellular components was determined by morphometric analysis to quantify the ultrastructure of early bovine embryos produced either in vivo or parthenogenetically after stimulation of oocytes by electric pulse AC/DC. In embryos obtained in vivo, most of cellular volume was occupied by cytoplasm (82.93%). The relative volume of lipids, vacuoles, mitochondria was relatively low (5.46; 5.07; 3.78%, respectively), and the relative volume of Golgi apparatus and cell inclusions was the lowest (1.51%). AC/DC-derived parthenogenotes had a relative high area occupied by vacuoles and lipids (18.68 vs. 14.33%) and a significantly lower relative volume was occupied by cytoplasm (60.63%) when compared with the control in vivo embryos. These observations demonstrated that parthenogenetic embryos had significantly altered ultrastructure, indicating extensive subcellular damages. These findings are discussed from the physiological and functional point of view.
Asunto(s)
Embrión de Mamíferos/efectos de la radiación , Embrión de Mamíferos/ultraestructura , Oocitos/efectos de la radiación , Oocitos/ultraestructura , Animales , Bovinos , Tamaño de la Célula/efectos de la radiación , Células Cultivadas , Transferencia de Embrión , Técnicas In Vitro , Partenogénesis/efectos de la radiaciónRESUMEN
In the current review, we summarize results of genetic analyses of "metabolic syndrome" in the spontaneously hypertensive rat (SHR). These results include (1) linkage analyses in the HXB/BXH recombinant inbred (RI) strains derived from SHR and Brown Norway (BN-Lx) strains which revealed quantitative trait loci (QTL) for hemodynamic and metabolic traits on several chromosomes, (2) genetic isolation of these putative QTL within differential chromosome segments of SHR.BN congenic strains, (3) detailed mapping of these QTL within limited chromosome segments of SHR.BN congenic sublines, (4) sequencing of selected positional candidate genes which revealed important mutations in the Cd36 and Srebp1 SHR genes, (5) functional tests of these candidate genes in SHR transgenic lines, and (6) integrated gene expression profiling and linkage mapping in RI strains which will be used to identify co-regulated genes and to determine co-segregation of transcriptional profiles with physiological and pathophysiological phenotypes.
Asunto(s)
Síndrome Metabólico/genética , Sitios de Carácter Cuantitativo , Animales , Animales Modificados Genéticamente , Mapeo Cromosómico , Expresión Génica , Hemodinámica/genética , Ratas , Ratas Endogámicas BN , Ratas Endogámicas SHRRESUMEN
Spontaneously hypertensive rats (SHR/NIH strain) harbor a deletion variant in the Cd36 fatty acid transporter and display defective fatty acid metabolism, insulin resistance and hypertension. Transgenic rescue of Cd36 in SHR ameliorates insulin resistance and improves dyslipidemia. However, the role of Cd36 in blood pressure regulation remains controversial due to inconsistent blood pressure effects that were observed with transgenic expression of Cd36 on the SHR background. In the current studies, we developed two new SHR transgenic lines, which express wild type Cd36 under the control of the universal Ef-1 alpha promoter, and examined the effects of transgenic expression of wild type Cd36 on selected metabolic and cardiovascular phenotypes. Transgenic expression of Cd36 in the new lines was associated with significantly decreased serum fatty acids, amelioration of insulin resistance and glucose intolerance but failed to induce any consistent changes in blood pressure as measured by radiotelemetry. The current findings confirm the genetic association of defective Cd36 with disordered insulin action and fatty acid metabolism in the SHR/NIH strain and suggest that Cd36 is linked to other gene(s) on rat chromosome 4 that regulate blood pressure.
Asunto(s)
Antígenos CD36/fisiología , Hiperlipidemias/metabolismo , Hipertensión/fisiopatología , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Animales , Animales Modificados Genéticamente , Área Bajo la Curva , Presión Sanguínea/genética , Presión Sanguínea/fisiología , Antígenos CD36/genética , Diafragma/efectos de los fármacos , Diafragma/metabolismo , Epidídimo/efectos de los fármacos , Epidídimo/metabolismo , Ácidos Grasos no Esterificados/sangre , Ácidos Grasos no Esterificados/metabolismo , Fructosa/administración & dosificación , Expresión Génica , Glucosa/metabolismo , Prueba de Tolerancia a la Glucosa , Hiperlipidemias/genética , Hipertensión/genética , Insulina/farmacología , Resistencia a la Insulina/genética , Resistencia a la Insulina/fisiología , Riñón/metabolismo , Metabolismo de los Lípidos , Hígado/metabolismo , Masculino , Músculos/efectos de los fármacos , Músculos/metabolismo , Miocardio/metabolismo , Factor 1 de Elongación Peptídica/genética , Ratas , Ratas Endogámicas SHR , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de TiempoRESUMEN
Completely concordant distributions of Cd36 and Rt8 deletion/null and wild-type alleles among inbred and congenic strains, together with Western blot analysis of RT8/CD36 proteins, indicated that the CD36 protein functions as an immunogenic domain of the RT8 alloantigen.
Asunto(s)
Antígenos CD36/inmunología , Isoantígenos/inmunología , Transportadores de Anión Orgánico/inmunología , Animales , Western Blotting , Humanos , Ratas , Ratas Endogámicas SHRRESUMEN
Early bovine precompacted embryos (1 to 8 blastomeres) were analysed by electron microscopy. The volume density of cellular components was determined by morphometric analysis to quantify the ultrastructure of early bovine embryos produced either in vivo or in vitro both after fertilisation by intracytoplasmic sperm injection (ICSI) or from electrically stimulated oocytes (AC/DC). In normal embryos obtained in vivo (control), most of the cellular volume was occupied by cytoplasm (82.93%). The relative volume of lipids, vacuoles, mitochondria, Golgi apparatus and inclusion bodies was minimal. In the group of embryos after parthenogenetic activation (AC/DC) a relatively high proportion of the volume was occupied by vacuoles and lipids (18.68% vs 14.33%). Early ICSI-derived embryos contained the lowest relative volume of cytoplasm (58.33%) compared with the control embryos (in vivo) and parthenogenetically AC/DC-activated embryos and a higher volume was occupied by lipids (13.25%) and vacuoles (12.92%). It is concluded that in vitro produced embryos have a significantly altered ultrastructure, indicating extensive cellular damage.
Asunto(s)
Blastómeros/ultraestructura , Partenogénesis , Inyecciones de Esperma Intracitoplasmáticas , Animales , Blastómeros/metabolismo , Bovinos , Citoplasma/ultraestructura , Estimulación Eléctrica , Femenino , Aparato de Golgi/ultraestructura , Metabolismo de los Lípidos , Masculino , Oocitos/fisiología , Vacuolas/ultraestructuraRESUMEN
The chromosome position of the Cd36 insert was determined by FISH in two rat transgenic lines (SHR/Ola-TgN(EF1aCd36)10Ipcv (SHR-TG10) and SHR/Ola-TgN(EF1aCd36)19Ipcv (SHR-TG19). The Cd36 transgene construct labelled with digoxigenin-11-dNTP was used as a probe in the FISH analysis. In accord with the previous finding that the SHR-TG10 harbours 6-8 copies of the transgene, the signals from both metaphase and interphase nuclei of SHR-TG10 preparations were rather strong and the probe hybridized to both copies of chromosome 1 at band q55. The probe hybridization to SHR-TG19 metaphase preparations also showed homozygosity of the transgene with localization of both copies to chromosome 11 at band q11. The signals were distinct but much weaker compared to the SHR-TG10, which again is in accord with the fact that the SHR-TG19 line harbours only a single copy of the transgene. In order to look for a possible impact of the insertion site neighbourhood upon the transgene phenotypic effect, we performed linkage mapping of the transgene in the SHR-TG19 line. By linkage mapping, the placement of the transgene to the proximal part of RNO11 was confirmed, the critical interval being 4 cM between D11Rat20 and D11Rat21, in good agreement with the RH map. Within the close neighbourhood of the inserted Cd36 transgene, there are several genes known to be expressed in kidney, and so the influence of some regulatory sequences enhancing kidney expression of the Cd36 transgene can be envisaged.
Asunto(s)
Antígenos CD36/genética , Mapeo Cromosómico , Organismos Modificados Genéticamente , Transgenes , Animales , Cromosomas de los Mamíferos , Etiquetas de Secuencia Expresada , Hibridación Fluorescente in Situ , Ratones , Ratas , Ratas Endogámicas SHR , Distribución TisularRESUMEN
Spontaneously hypertensive rats (SHR) display several features of the human insulin-resistance syndromes. Cd36 deficiency is genetically linked to insulin resistance in SHR. We show that transgenic expression of Cd36 in SHR ameliorates insulin resistance and lowers serum fatty acids. Our results provide direct evidence that Cd36 deficiency can promote defective insulin action and disordered fatty-acid metabolism in spontaneous hypertension.
Asunto(s)
Antígenos CD36/genética , Hipertensión/genética , Resistencia a la Insulina/genética , Animales , Animales Modificados Genéticamente , Antígenos CD36/biosíntesis , Ácidos Grasos/sangre , Prueba de Tolerancia a la Glucosa , Ratas , Ratas Endogámicas SHRRESUMEN
WAP is being recognized as the principal milk protein expressed in pregnant or lactating females of several mammalian species. Recently, it has been shown that the 6.3-kb 5' untranslated region of the rWAP gene is able to control, and almost completely restrict, the expression of the transgene into the mammary gland of the transgenic animal. We cloned the genomic fragment carrying the rWAP gene locus from the rabbit phage genomic library and used the 8.5-kb long 5' untranslated part of the rWAP gene to target the expression of hEPO, cloned from the human phage genomic library, into the mammary gland of the mouse. The vectors, carrying either the hEPO gene or the rWAP-hEPO hybrid gene, were injected into the mouse ova, and 12 transgenic animals were identified by PCR and Southern blot from the progeny of 168 tested littermates. Transgenic mice were viable, fertile and displayed a normal development. Recombinant human erythropoietin was produced in the milk of a transgenic mouse female at a secretion level of 5.3 mIU/ml, as detected by ELISA. Despite the low production of the transgenic glycoprotein in the milk we demonstrate that the hybrid gene can be expressed in the mammary gland of the host animal. Thus, WAP-based recombinant vectors, with additional optimizing modifications, can be useful for production of therapeutic proteins in the transgenic mammals.
Asunto(s)
Eritropoyetina/genética , Glándulas Mamarias Animales/fisiología , Proteínas de la Leche/genética , Animales , Eritropoyetina/sangre , Femenino , Expresión Génica , Humanos , Ratones , Ratones Transgénicos , Microinyecciones , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas/genética , TransgenesRESUMEN
The SHR is the most widely studied animal model of hypertension. In this strain, as in many humans with essential hypertension, increased blood pressure has been reported to cluster with other risk factors for cardiovascular disease, including insulin resistance and dyslipidemia. However, the genetic mechanisms that mediate this clustering of risk factors for cardiovascular disease or the hypertension "metabolic syndrome" remain poorly understood. In the current studies, we have demonstrated (1) that a gene or genes responsible for a whole spectrum of cardiovascular risk factors mapped to a limited segment of the centromeric region of rat chromosome 4, (2) that a spontaneous deletion in the gene for Cd36 that encodes a fatty acid transporter and is located directly at the peak of QTL linkages on chromosome 4 has been indirectly linked to the transmission of insulin resistance, defective fatty acid metabolism, and increased blood pressure, and (3) based on complementation analysis in two transgenic lines expressing wild-type Cd36 on the genetic background of the SHR strain harboring the deletion variant of Cd36, we have established that defective Cd36 can be a determinant of disordered fatty acid metabolism, glucose intolerance, and insulin resistance in spontaneous hypertension.